|
1
|
Takeshita S, Kikuno R, Tezuka K and Amann
E: Osteoblast-specific factor 2: Cloning of a putative bone
adhesion protein with homology with the insect protein fasciclin I.
Biochem J. 294:271–278. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Horiuchi K, Amizuka N, Takeshita S,
Takamatsu H, Katsuura M, Ozawa H, Toyama Y, Bonewald LF and Kudo A:
Identification and characterization of a novel protein, periostin,
with restricted expression to periosteum and periodontal ligament
and increased expression by transforming growth factor beta. J Bone
Miner Res. 14:1239–1249. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takayama G, Arima K, Kanaji T, Toda S,
Tanaka H, Shoji S, McKenzie AN, Nagai H, Hotokebuchi T and Izuhara
K: Periostin: A novel component of subepithelial fibrosis of
bronchial asthma downstream of IL-4 and IL-13 signals. J Allergy
Clin Immunol. 118:98–104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ji X, Chen D, Xu C, Harris SE, Mundy GR
and Yoneda T: Patterns of gene expression associated with
BMP-2-induced osteoblast and adipocyte differentiation of
mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab.
18:132–139. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Erkan M, Kleeff J, Gorbachevski A, Reiser
C, Mitkus T, Esposito I, Giese T, Büchler MW, Giese NA and Friess
H: Periostin creates a tumor-supportive microenvironment in the
pancreas by sustaining fibrogenic stellate cell activity.
Gastroenterology. 132:1447–1464. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li P, Oparil S, Feng W and Chen YF:
Hypoxia-responsive growth factors upregulate periostin and
osteopontin expression via distinct signaling pathways in rat
pulmonary arterial smooth muscle cells. J Appl Physiol (1985).
97:1549–1558. 2004. View Article : Google Scholar
|
|
7
|
Norris RA, Damon B, Mironov V, Kasyanov V,
Ramamurthi A, Moreno-Rodriguez R, Trusk T, Potts JD, Goodwin RL,
Davis J, et al: Periostin regulates collagen fibrillogenesis and
the biomechanical properties of connective tissues. J Cell Biochem.
101:695–711. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gillan L, Matei D, Fishman DA, Gerbin CS,
Karlan BY and Chang DD: Periostin secreted by epithelial ovarian
carcinoma is a ligand for alpha(V)beta(3) and alpha(V)beta(5)
integrins and promotes cell motility. Cancer Res. 62:5358–5364.
2002.PubMed/NCBI
|
|
9
|
Tkatchenko TV, Moreno-Rodriguez RA, Conway
SJ, Molkentin JD, Markwald RR and Tkatchenko AV: Lack of periostin
leads to suppression of Notch1 signaling and calcific aortic valve
disease. Physiol Genomics. 39:160–168. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sriram R, Lo V, Pryce B, Antonova L, Mears
AJ, Daneshmand M, McKay B, Conway SJ, Muller WJ and Sabourin LA:
Loss of periostin/OSF-2 in ErbB2/Neu-driven tumors results in
androgen receptor-positive molecular apocrine-like tumors with
reduced Notch1 activity. Breast Cancer Res. 17:72015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu Y and Liu BA: Enhanced proliferation,
invasion, and epithelial-mesenchymal transition of
nicotine-promoted gastric cancer by periostin. World J
Gastroenterol. 17:2674–2680. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tai IT, Dai M and Chen LB: Periostin
induction in tumor cell line explants and inhibition of in vitro
cell growth by anti-periostin antibodies. Carcinogenesis.
26:908–915. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pawar H, Kashyap MK, Sahasrabuddhe NA,
Renuse S, Harsha HC, Kumar P, Sharma J, Kandasamy K, Marimuthu A,
Nair B, et al: Quantitative tissue proteomics of esophageal
squamous cell carcinoma for novel biomarker discovery. Cancer Biol
Ther. 12:510–522. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kashyap MK, Marimuthu A, Kishore CJ, Peri
S, Keerthikumar S, Prasad TS, Mahmood R, Rao S, Ranganathan P,
Sanjeeviah RC, et al: Genomewide mRNA profiling of esophageal
squamous cell carcinoma for identification of cancer biomarkers.
Cancer Biol Ther. 8:36–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Underwood TJ, Hayden AL, Derouet M, Garcia
E, Noble F, White MJ, Thirdborough S, Mead A, Clemons N, Mellone M,
et al: Cancer-associated fibroblasts predict poor outcome and
promote periostin-dependent invasion in oesophageal adenocarcinoma.
J Pathol. 235:466–477. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Luo JH, Zhou J and Gao Y: Correlation
between periostin and SNCG and esophageal cancer invasion,
infiltration and apoptosis. Asian Pac J Trop Med. 6:516–519. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang W, Sun QK, He YF, Ma DC, Xie MR, Ji
CS and Hu B: Overexpression of periostin is significantly
correlated to the tumor angiogenesis and poor prognosis in patients
with esophageal squamous cell carcinoma. Int J Clin Exp Pathol.
7:593–601. 2014.PubMed/NCBI
|
|
18
|
Cheng JC, Graber MS, Hsu FM, Tsai CL,
Castaneda L, Lee JM, Chang DT and Koong AC: High serum levels of
vascular endothelial growth factor-A and transforming growth
factor-β1 before neoadjuvant chemoradiotherapy predict poor
outcomes in patients with esophageal squamous cell carcinoma
receiving combined modality therapy. Ann Surg Oncol. 21:2361–2368.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shang L, Liu HJ, Hao JJ, Jiang YY, Shi F,
Zhang Y, Cai Y, Xu X, Jia XM, Zhan QM and Wang MR: A panel of
overexpressed proteins for prognosis in esophageal squamous cell
carcinoma. PLoS One. 9:e1110452014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Okawa T, Michaylira CZ, Kalabis J, Stairs
DB, Nakagawa H, Andl CD, Johnstone CN, Klein-Szanto AJ, El-Deiry
WS, Cukierman E, et al: The functional interplay between EGFR
overexpression, hTERT activation, and p53 mutation in esophageal
epithelial cells with activation of stromal fibroblasts induces
tumor development, invasion, and differentiation. Genes Dev.
21:2788–2803. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Michaylira CZ, Wong GS, Miller CG,
Gutierrez CM, Nakagawa H, Hammond R, Klein-Szanto AJ, Lee JS, Kim
SB, Herlyn M, et al: Periostin, a cell adhesion molecule,
facilitates invasion in the tumor microenvironment and annotates a
novel tumor-invasive signature in esophageal cancer. Cancer Res.
70:5281–5292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wong GS, Lee JS, Park YY, Klein-Szanto AJ,
Waldron TJ, Cukierman E, Herlyn M, Gimotty P, Nakagawa H and Rustgi
AK: Periostin cooperates with mutant p53 to mediate invasion
through the induction of STAT1 signaling in the esophageal tumor
microenvironment. Oncogenesis. 2:e592013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kwon YJ, Lee SJ, Koh JS, Kim SH, Kim YJ
and Park JH: Expression patterns of aurora kinase B, heat shock
protein 47, and periostin in esophageal squamous cell carcinoma.
Oncol Res. 18:141–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li JS, Sun GW, Wei XY and Tang WH:
Expression of periostin and its clinicopathological relevance in
gastric cancer. World J Gastroenterol. 13:5261–5266. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kikuchi Y, Kunita A, Iwata C, Komura D,
Nishiyama T, Shimazu K, Takeshita K, Shibahara J, Kii I, Morishita
Y, et al: The niche component periostin is produced by
cancer-associated fibroblasts, supporting growth of gastric cancer
through ERK activation. Am J Pathol. 184:859–870. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lv H, Liu R, Fu J, Yang Q, Shi J, Chen P,
Ji M, Shi B and Hou P: Epithelial cell-derived periostin functions
as a tumor suppressor in gastric cancer through stabilizing p53 and
E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Cell Cycle. 13:2962–2974. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Qiu F, Shi CH, Zheng J and Liu YB:
Periostin mediates the increased pro-angiogenic activity of gastric
cancer cells under hypoxic conditions. J Biochem Mol Toxicol.
27:364–369. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li B, Wang L and Chi B: Upregulation of
periostin prevents P53-mediated apoptosis in SGC-7901 gastric
cancer cells. Mol Biol Rep. 40:1677–1683. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Haupt S, Berger M, Goldberg Z and Haupt Y:
Apoptosis - the p53 network. J Cell Sci. 116:4077–4085. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ben QW, Zhao Z, Ge SF, Zhou J, Yuan F and
Yuan YZ: Circulating levels of periostin may help identify patients
with more aggressive colorectal cancer. Int J Oncol. 34:821–828.
2009.PubMed/NCBI
|
|
31
|
Kikuchi Y, Kashima TG, Nishiyama T,
Shimazu K, Morishita Y, Shimazaki M, Kii I, Horie H, Nagai H, Kudo
A and Fukayama M: Periostin is expressed in pericryptal fibroblasts
and cancer-associated fibroblasts in the colon. J Histochem
Cytochem. 56:753–764. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wu G, Wang X and Zhang X: Clinical
implications of periostin in the liver metastasis of colorectal
cancer. Cancer Biother Radiopharm. 28:298–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bao S, Ouyang G, Bai X, Huang Z, Ma C, Liu
M, Shao R, Anderson RM, Rich JN and Wang XF: Periostin potently
promotes metastatic growth of colon cancer by augmenting cell
survival via the Akt/PKB pathway. Cancer Cell. 5:329–339. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xiao ZM, Wang XY and Wang AM: Periostin
induces chemoresistance in colon cancer cells through activation of
the PI3K/Akt/survivin pathway. Biotechnol Appl Biochem. 62:401–406.
2015. View
Article : Google Scholar : PubMed/NCBI
|
|
35
|
Malanchi I, Santamaria-Martínez A, Susanto
E, Peng H, Lehr HA, Delaloye JF and Huelsken J: Interactions
between cancer stem cells and their niche govern metastatic
colonization. Nature. 481:85–89. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Argellati F, Nuzzo PV, Ricci F, Mangerini
R, Rubagotti A and Boccardo F: Dihydrotestosterone and bicalutamide
do not affect periostin expression in androgen-dependent LNCaP
prostate cancer cell lines. Anticancer Res. 33:815–820.
2013.PubMed/NCBI
|
